Baillie Gifford Us Growth Share Discussion Threads

[29palms] 22/9/2020 20:45

About to launch a charge on all time high of £2.60 with 2.9% gain today and trading at a Premium to NAV
This evening's nice uptick on NASDAQ will help along with addition to FTSE250 yesterday - 21st Sept.
Currently the Trust is showing an 84% gain over last 52 weeks.

As always,
DYOR

[joy division still] 10/9/2020 23:21

Missed the boat on this fund, was my pick of tech ITs, gonna sit on hands and cash for now, but this looks well managed in a great sector, just too expensive at the mo for my tight fistedness

[29palms] 10/9/2020 17:34

2 days in a row we have RNS on "Issue of Equity" stating "in order to meet ongoing market demand"

Tracker Funds prob picking up stock before entry in FTSE250 on Monday 21st Sept.

As always,
DYOR

[29palms] 03/9/2020 12:25

From September 21st FTSE 250 Additions include:

Baillie Gifford US Growth Trust

Should see an uplift in trading and share price due to being picked up by FTSE250 Tracker Funds.

As always,
DYOR

[vraic] 02/9/2020 18:51

Interesting the issue of shares today is the first in 2 months.
Annual figs and annual report due soon.
Remain a long term holder.
Market cap £681 million , this trust has come a long way in 2 1/2 years,
Well done all at BG.

DYOR

[29palms] 01/9/2020 10:37

Not only do we have TSLA in "Melt Up" situ, today we have holding ZM showing a 27% gain in Pre-Market Trading hours.

Should enhance the NAV

As always,
DYOR

[29palms] 28/8/2020 16:38

Top performers on NASDAQ over past week are-
1: WDAY
2: TSLA

Both holdings in the US Growth Trust and will only enhance the NAV update on 1st Sept.

As always,
DYOR

[29palms] 21/8/2020 11:15

TSLA pre-market trading @ $2,055
Another fill up to NAV

As always,
DYOR

[29palms] 20/8/2020 21:45

TSLA closes on NASDAQ at new record high of $2,001.83 with new all time Intra Day high of $2021.87
Currently trading in after hours around $2013

Will provide another fill up to NAV

As always,
DYOR

[29palms] 18/8/2020 11:20

Pre market trading on TSLA:$1913

Another fill up to NAV

[29palms] 17/8/2020 22:10

New all time high for TSLA at close and holding strong in "after hours trading"

Another fill up to NAV

As always,
DYOR

[29palms] 02/8/2020 22:26

SpaceX mission to ISS completed safely with splash down off Florida coast @ 7.48pm UK time 👏👏👏👏
Will enhance value attributed to unlisted holding in the portfolio.

[29palms] 22/7/2020 21:44

TSLA earnings after the bell.
Earnings: $2.18 (ex-items) vs. 3 cents per share, expected.
Revenue: $6.04 billion vs. $5.37 billion, expected.

Will provide a nice fill up to NAV

[29palms] 14/7/2020 23:20

The good news just keeps on coming:


As always,
DYOR

[29palms] 13/7/2020 11:36

TSLA Pre-market trading @ $1,627
Another fill up to NAV

As always,
DYOR

[vraic] 11/7/2020 14:45

TSLA possible candidate for entry into Standard and Poor 500 comp index.

Market cap now £ 605 million . Annual figs soon , managers report will
make for very interesting reading.
Remains a good long term story.
Well done BG.

dyor

[killing_time] 11/7/2020 10:34

Bought in for the first time yesterday, about 1.5% of portfolio. Been watching for ages.
What i like is there unlisted holding in Space X which is about 1.5% of there portfolio. Think this will one day be the biggest company in the world, currently valued at about $33 billion. Elon said they will float Space X on the market when they start flying to Mars. The first cargo flights are due to go in 2022 with manned flights in 2024.

Also hold SMT which has Space X. KT.

[29palms] 10/7/2020 22:15

TSLA closed on Nasdaq this evening @ $1,544.64 +$150.37

Will provide a nice uplift on NAV

As always,
DYOR

[29palms] 19/6/2020 11:15

TSLA showing pre market to open around $1018
Another fill up to NAV

[29palms] 16/6/2020 10:15

Nice to see some confidence in Quilter adding circa 2.6m shares to their already healthy holding.
Now holding 13% of the equity.

[29palms] 10/6/2020 15:54

TSLA share price $1000+

Should provide a nice fill up to NAV

[29palms] 31/5/2020 19:44

FWIW
As at 31st March 2020 portfolio valuation includes, as Unlisted Equity, Space Exploration Technologies and valuation circa £7m

Given momentous and successful events this weekend in SpaceX launch and dock with ISS I would imagine valuation of SpaceX holdings will merit a healthy increase in value.
As always,
DYOR

[whitestone] 18/5/2020 18:04

The funds behind the US stock lifting Covid-19 vaccine hopes

By Daniel Grote 18 May, 2020 at 16:18

The funds behind the US stock lifting Covid-19 vaccine hopes
Baillie Gifford is among the major backers of Moderna (MRNA.O), the US biotechnology company which has sent stock markets rallying with news of a promising early trial for its experimental Covid-19 vaccine.

Shares in Moderna have surged 25% after the company reported promising results from an early study of the vaccine conducted by the US National Institutes of Health. Eight patients who were administered the vaccine were found to have antibody levels similar to those that have recovered from the coronavirus.

‘We are investing to scale up manufacturing so we can maximize the number of doses we can produce to help protect as many people as we can from Sars-CoV-2,’ said Stéphanie Bancel, Moderna chief executive.

Global stock markets were also lifted by the news, on hopes a medical breakthrough in the fight against the coronavirus pandemic could allow locked-down economies to reopen more quickly. The FTSE 100 was up 3.3% at 5,993 while in the US, the S&P 500 opened 2.5% higher.

Growth-focused Edinburgh fund group Baillie Gifford is among the major backers of Moderna, holding just under 1% of the shares in a stake worth $284m, according to Refinitiv data. Moderna shares have soared 338% since the turn of the year on investor hopes over the progress of its coronavirus vaccine.

The fund group’s two best-performing funds of the last three years hold the stock. The £3.5bn Baillie Gifford American fund, up 117.7% over the last 36 months, has an $83.8bn stake, according to Refinitiv data accounting for around 2% of the portfolio.

The £405m Baillie Gifford Positive Change fund, the best-performing fund in the Investment Association’s Global sector over the last three years, also holds the shares. It holds a $19.4m position according to Refintiv, accounting for around 3.8% of the portfolio.

Shares in the £483m Baillie Gifford US Growth (USA) investment trust were up 3.8% at 193p today, thanks in part to its $9.4m position in Moderna shares.

BB Biotech (BION.AS) was meanwhile up 4.5% at 66.75 CHF, boosted by the £3bn Swiss investment company’s 4% portfolio stake in the stock according to the latest factsheet.

BB Biotech and Baillie Gifford were early backers of Moderna, with Baillie Gifford having invested in the stock at its flotation in December 2018. Linden Thomson, manager of the £468m AXA Framlington Biotech fund, is a more recent convert, having bought the shares in March.

‘We initiated a position in Moderna Therapeutics, which has one of the most advanced programmes to develop a vaccine against Covid-19,’ she said in her most recent update to investors. Refinitiv data shows she has built a position worth $11.9m, or around 2% of her fund.

Two exchange-traded funds have significant positions in the shares. The £102m iShares Nasdaq US Biotechnology Ucits ETF, up 2.7% today, has a 2% portfolio position according to its latest factsheet, while the $18.6m L&G Healthcare Breakthrough Ucits ETF has a 1.1% position, according to Refinitiv.

[29palms] 18/5/2020 13:49

Huge jump in pre trade for holding MRNA will provide a nice fill up to NAV
As always,
DYOR